A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 100.57
GOOG 584.49
MSFT 44.95
BAC 15.52
FB 74.81

Recently Added

LB 62.98
TXTR 29.46
CHGG 6.98
MATR 4.77
TRXC 8.60

Gaining Speed

TXTR 29.46
ACTG 17.26
TIVO 13.55
LB 62.98
GAIA 7.14

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More

Get Alerted When News Hits On This Stock - FREE!